- Prev Rank-
- LocationPhiladelphia, Pa.
- IndustryPharmaceuticals
- SectorHealth Care
- F1000 Rank-
- G500 Rank-
- Current Streak-
Generic drugs save customers money—and they’re a windfall for makers like Lannett, which enjoyed blockbuster EPS growth of 229% in 2013.
Looking for leads, investment insights, or competitive intelligence?Get Premium Access
Company Information
| Location | Philadelphia, Pa. |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Current Streak | - |
Revenue, Net Income
| Revenue Past Four Quarters | 233 |
| Net Income Past Four Quarters | 37.1 |
Growth Rates & Ranks
| EPS Growth Rank | 24 |
| EPS 3 yr Annual Growth Rate Pct | 86 |
| Revenue Growth Rank | 95 |
| Rev 3 yr Annual Growth Rate | 22 |
| Total Return 3 yr Annual Rate | 115 |
| Total Return Rank | 2 |
| Beat S&P 3 yr Annual Growth Rate? | yes |
| P/E current fiscal year profits (est.) | 16 |
